Effect of synbiotic in cystic fibrosis
Phase 1
Recruiting
- Conditions
- Cystic fibrosis.E84.0 Cystic fibrosis with pulmonary manifestations
- Registration Number
- IRCT2017011732004N1
- Lead Sponsor
- Pediatric health research center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 40
Inclusion Criteria
children with cystic fibrosis; aged between 5-12 years
exclusion criteria: having other disease including diabetes; cirrhosis; hypo-albominemia; ventilator dependent respiratory failure
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anthropocentric measures. Timepoint: before supplementation and every month after supplementation for 6 month. Method of measurement: scale and stadiomete.;Diarehea. Timepoint: Before supplementation and every month after supplementation for 6 month. Method of measurement: Questionnaire.;Quality of life. Timepoint: before supplementation and every month after supplementation for 6 month. Method of measurement: Questionnaire.;Antibiotic treatment (oral and IV therapy). Timepoint: before supplementation and 2, 4 and 6 month after supplemenattion. Method of measurement: Questionnaire.;Hospitalization. Timepoint: before supplementation and every month after supplementation for 6 month. Method of measurement: Questionnaire.
- Secondary Outcome Measures
Name Time Method Serum total antioxidant. Timepoint: before and after six month of supplementation. Method of measurement: commercial kit.